BioCentury
ARTICLE | Clinical News

Vacc-4x: Completed Phase II enrollment

February 6, 2012 8:00 AM UTC

Last month, Bionor completed enrollment of 24 HIV-infected patients stable on anti-retroviral therapy (ART) in a single-blind, placebo-controlled, Norwegian Phase II trial evaluating intranasal Vacc-4...